FindTrial
Sign In

Fluorine F 18 Ara-G

DRUG2 trials

Sponsors

Lawrence Fong, University of California, Davis

Conditions

Advanced Lung Non-Small Cell CarcinomaBladder CancerMetastatic Lung Non-Small Cell CarcinomaStage III Lung Cancer AJCC v8Stage IIIA Lung Cancer AJCC v8Stage IIIB Lung Cancer AJCC v8Stage IIIC Lung Cancer AJCC v8Stage IV Lung Cancer AJCC v8

Early Phase 1

[18F]-AraG for the Detection of T-Cell Activation in Advanced Non-small Cell Lung Cancer Patients Undergoing PD-1/PD-L1-Directed Therapy
WithdrawnNCT04186988
University of California, DavisAdvanced Lung Non-Small Cell Carcinoma, Metastatic Lung Non-Small Cell Carcinoma, Stage IIIA Lung Cancer AJCC v8 +6
Start: 2019-11-05End: 2020-03-12Updated: 2022-02-01

Phase 2

Functional Imaging of T-Cell Activation With [18F]F-AraG in Urothelial Carcinoma Patients Receiving Neoadjuvant Therapy or Patients With Cancer Receiving Standard of Care Anti-PD-1/L1
TerminatedNCT03007719
Lawrence FongBladder Cancer
Start: 2017-03-07End: 2019-01-11Updated: 2020-01-21